PGP and cancer: 23-Hydroxybetulinic acid has an anticancer effect and re-sensitizes chemotherapy-resistant cancer cells, while its piperidinyl derivatives act as specific P-gp-reversing agents significantly enhancing the toxicity of doxorubicin (Dox), vincristine, and paclitaxel [16,17].